Powering The Future Of Genetic Medicines
4D Molecular Therapeutics (4DMT) (4dmt.com) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 44th percentile of 16292 Healthcare brands.
4D Molecular Therapeutics (4DMT) is a biotherapeutics company that designs, develops, and commercializes gene therapeutic products for serious unmet medical conditions. The company uses a proprietary directed evolution platform to create customized and enhanced viral vectors for genetic medicines, with a particular focus on retinal and pulmonary diseases. 4DMT aims to provide transformative benefit or potential cures for patients through its vector platform and product development engine.
| Brand Name | 4D Molecular Therapeutics (4DMT) |
|---|---|
| Domain | 4dmt.com |
| Industry | Healthcare |
| Main Competitors | Adverum Biotechnologies (82/100), REGENXBIO (74/100), Spark Therapeutics (74/100), Applied Genetic Technologies Corporation (AGTC) (80/100), Ocugen (74/100), Sarepta Therapeutics (83/100), BioMarin Pharmaceutical (58/100) |
Moz Domain Authority 16/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is 4D Molecular Therapeutics (4DMT)?", Claude could identify the brand as of October 2026. 4D Molecular Therapeutics is a clinical-stage biotechnology company developing gene therapies using its proprietary Therapeutic Vector Evolution platform to engineer novel adeno-associated virus (AAV) vectors. Its lead programs target ophthalmology (such as wet AMD with 4D-150) a Best known for Its AAV vector engineering platform (Therapeutic Vector Evolution) used to create customized gene therapies, especially for eye diseases like wet AMD.
When asked "Best brands similar to 4D Molecular Therapeutics (4DMT)?", Claude would recommend 4D Molecular Therapeutics (4DMT) as of October 2026. It's a notable player in next-generation gene therapy vector design, so it would come up in discussions of innovative AAV-based biotech companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
4D Molecular Therapeutics (4DMT)'s main competitors in Healthcare: Adverum Biotechnologies (82/100), REGENXBIO (74/100), Spark Therapeutics (74/100), Applied Genetic Technologies Corporation (AGTC) (80/100), Ocugen (74/100).
Sources: Brand Analyzer scan
4D Molecular Therapeutics (4DMT) is a biotherapeutics company that designs, develops, and commercializes gene therapeutic products aimed at treating serious unmet medical conditions.
4D Molecular Therapeutics (4DMT) has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 39, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
4DMT offers gene therapeutic products developed through its proprietary directed evolution vector platform, focused primarily on treatments for retinal and pulmonary diseases, designed to provide transformative or curative benefits for patients with serious unmet medical needs.
4D Molecular Therapeutics (4DMT) scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
4DMT is known for its proprietary directed evolution platform used to invent customized and enhanced vectors for gene therapies, particularly targeting retinal and pulmonary diseases.
4D Molecular Therapeutics (4DMT) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
4DMT's gene therapies are intended for patients suffering from serious unmet medical conditions, particularly those with retinal and pulmonary diseases. Its work also involves physicians who administer or prescribe these therapies, patients' families, and patient advocacy organizations engaged in these disease areas.
4D Molecular Therapeutics (4DMT) scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
4D Molecular Therapeutics (4DMT) has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and a low Moz Domain Authority of 16/100. In a live check, Claude could already identify 4D Molecular Therapeutics (4DMT) from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to 4D Molecular Therapeutics (4DMT): 4D Molecular Therapeutics (4DMT) (75/100), 321 STRONG (75/100), AACP (Acupuncture Association of Chartered Physiotherapists) (75/100), AAMFT (American Association for Marriage and Family Therapy) (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.